Analysis of Neftx vs. Traditional Aggregators: A Case Study of Dermatology Clinics

Executive Summary

This white paper provides a comparative analysis of patient acquisition strategies for dermatology clinics, focusing on traditional aggregators and Neftx. It demonstrates the superior financial performance of Neftx through a mathematical model that highlights its advantages in patient acquisition, retention, and overall revenue. This analysis underscores the potential of platforms like Neftx to shape the future of patient acquisition and management in the healthcare industry.

Key Points:

• Increased Revenue and Profitability: Neftx enables higher total revenue and profit margins for dermatology clinics compared to traditional aggregators, even after accounting for marketing and subscription costs. Neftx eliminates intermediary fees and minimizes revenue loss from cross-promotion, allowing clinics to retain a larger portion of their earnings.
• Stronger Patient Relationships and Loyalty: By connecting directly with patients, doctors can foster stronger relationships and build lasting loyalty. This direct connection eliminates the reliance on intermediaries, giving doctors more control over patient interactions.
• Improved Patient Retention and Lifetime Value: Comprehensive patient management tools enhance engagement and retention, leading to sustained revenue growth. Increased patient retention contributes to higher lifetime value (LTV) from each patient.
• Effective Patient Acquisition: Neftx's advanced digital marketing and SEO tools attract more patients compared to traditional aggregators. This results in consistent patient acquisition and practice growth.
• Future-Proofing Your Practice: Platforms like Neftx are revolutionizing patient acquisition and management in healthcare. Adopting Neftx positions practices for long-term success in the evolving healthcare landscape.

Introduction

Dermatology clinics face significant challenges in managing patient acquisition, retention, and overall profitability. Traditional aggregators provide an initial influx of patients but often lead to hidden costs and revenue loss. Neftx offers a comprehensive solution that not only drives patient acquisition but also enhances patient management and engagement. This white paper uses a mathematical model to compare the financial outcomes of using traditional aggregators versus Neftx, showcasing the advantages of adopting Neftx for dermatology clinics.

Patient Acquisition Models: Traditional Aggregators vs. Neftx

Traditional Aggregators:

Traditional aggregators connect patients with healthcare providers through a fee-based model. They facilitate initial patient connections but may include fees and cross-referrals that can impact overall clinic revenue.

Neftx:

Neftx provides a direct-to-patient approach, utilizing advanced digital marketing, SEO, and patient management tools. This model aims to enhance patient retention and optimize revenue by reducing intermediary fees and cross-referrals.

Case Study: Dermatology Clinic Using Neftx vs. Traditional Aggregators

Data for Calculations:

• Average consultation fee: ₹500 (both Neftx and aggregator)
• Aggregator fee: 28%
• Average procedure revenue per patient: ₹5,000
• Average pharmacy revenue per patient: ₹3,231
• Number of consultations per patient: 1.27
• Percentage of patients undergoing procedures: 66%
• Patients booked through SEO or Neftx website module: 26 (for 500 patients), 53 (for 1000 patients)

Calculations for 500 Patients:

Conclusion

By using Neftx instead of traditional aggregators, dermatology clinics can achieve significantly higher total revenue. The loss of revenue due to aggregator fees and cross-promotion is substantial, making Neftx a more financially beneficial option for clinics aiming to maximize their revenue.

Appendix

Mathematical Model for Financial Comparison

Consultation Fees and Revenue Management:

Let:

• C be the average consultation fee.
• F be the aggregator fee percentage.
• N be the number of patients per month.

Traditional Aggregators:

Net consultation revenue per patient: C × (1 − F)

Total monthly consultation revenue: N × C × (1 − F)

Neftx:

Net consultation revenue per patient: C

Total monthly consultation revenue: N × C

Procedures and Follow-Up Visits:

Let:

• P be the average revenue per procedure.
• L be the revenue loss percentage due to cross-promotion.

Based on a good sample size, it is observed that on average, 50% of patients undergo procedures.

Traditional Aggregators:

Net revenue per procedure: P × (1 − L)

Total monthly revenue from procedures: N × 0.5 × P × (1 − L)

Neftx:

Net revenue per procedure: P

Total monthly revenue from procedures: N × 0.5 × P

Pharmacy Revenue:

Let:

• R be the monthly pharmacy revenue.
• M be the revenue loss percentage due to cross-promotion.

Based on a good sample size, the pharmacy revenue per patient can be calculated as follows:

Total pharmacy revenue / Total number of patients.

Traditional Aggregators:

Net pharmacy revenue: R × (1 − M)

Revenue from aggregator patients: R × 0.1 × (1 − M)

Neftx:

Net pharmacy revenue: R

Revenue from Neftx patients: R × 0.1

Total Revenue and Net Profit:

Traditional Aggregators:

Total monthly revenue: N × C × (1 − F) + N × 0.5 × P × (1 − L) + R × (1 − M)

Net revenue after fees: N × C × (1 − F) + N × 0.5 × P × (1 − L) + R × (1 − M) − F × N × C

Profit margin: Total revenue / Net revenue × 100

Neftx:

Total monthly revenue: N × C + N × 0.5 × P + R

Total monthly cost: D (Digital Marketing and Subscription)

Net revenue after costs: N × C + N × 0.5 × P + R − D

Profit margin: Total revenue / Net revenue × 100

Lifetime Value (LTV) Analysis

The Lifetime Value (LTV) of a patient is a critical metric for evaluating the long-term financial benefits of different patient acquisition strategies. LTV represents the total revenue a clinic can expect from a patient over their entire relationship with the clinic.

Let:

• LTV be the average lifetime value of a patient.
• V be the average revenue per visit.
• F be the average number of follow-up visits per patient.

Traditional Aggregators:

Aggregator impact on LTV: Reduced due to cross-promotions and patient switching.

LTV(aggregator) = C + F × (V × (1 − M))

Neftx:

Neftx impact on LTV: Enhanced due to better patient retention and engagement.

LTV(Neftx) = C + F × V

Based on a good sample size, it is observed that the average number of follow-up visits per patient is consistent and contributes significantly to the overall LTV.

Revenue Lost Analysis

Traditional Aggregators:

• Consultation Revenue Lost:
• Potential revenue: N × C
• Actual revenue: N × C × (1 − F)
• Revenue lost: N × C × F
• Procedure Revenue Lost:
• Potential revenue: N × 0.5 × P
• Actual revenue: N × 0.5 × P × (1 − L)
• Revenue lost: N × 0.5 × P × L
• Pharmacy Revenue Lost:
• Potential revenue: R
• Actual revenue: R × (1 − M)
• Revenue lost: R × M
• Total Revenue Lost:
• Consultation revenue lost: N × C × F
• Procedure revenue lost: N × 0.5 × P × L
• Pharmacy revenue lost: R × M
• Total revenue lost: N × C × F + N × 0.5 × P × L + R × M

Neftx: Neftx eliminates revenue loss associated with traditional aggregators, ensuring that clinics retain full revenue from consultations, procedures, and pharmacy sales.

Enhanced Patient Acquisition with Neftx

SEO and Digital Marketing:

Current Patient Acquisition via SEO:

• Monthly: S
• Yearly: S × 12

Increase with Blogs:

• Additional 5%: S × 0.05
• Total: S × 1.05

Increase with Word-of-Mouth:

• Additional 10%: S × 0.10
• Total: S × 1.15

Total Monthly Acquired Patients:

• Current: T (SEO + WhatsApp)
• With Blogs and Word-of-Mouth: T × 1.15

Revenue Projections for Enhanced Marketing:

• Monthly Consultation Revenue: T × 1.15 × C
• Monthly Procedures Revenue: (T × 1.15 × 0.50) × P
• Monthly Pharmacy Revenue: Assuming 10% increase: R × 1.10